Skip to main contentSkip to navigationSkip to search
Pandox logo
Pandox logo

Important Disclaimer

Offer by a consortium formed of joint offerors Pandox AB and Eiendomsspar AS (the “Consortium”) to acquire the entire issued and to be issued ordinary share capital of Dalata Hotel Group plc (“Dalata”), other than those Dalata shares in the beneficial ownership of the Consortium (the “Offer”).

THIS SECTION OF THE WEBSITE CONTAINS ANNOUNCEMENTS, DOCUMENTS, COMMUNICATIONS AND INFORMATION (TOGETHER THE “INFORMATION”) RELATING TO THE OFFER IN COMPLIANCE WITH THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 (THE “IRISH TAKEOVER RULES”). THE INFORMATION IS BEING MADE AVAILABLE IN GOOD FAITH AND FOR INFORMATION PURPOSES ONLY, AND ITS AVAILABILITY IS SUBJECT TO THE TERMS AND CONDITIONS SET OUT BELOW. 

ACCESS TO THIS SECTION OF THE WEBSITE MAY BE RESTRICTED UNDER SECURITIES LAWS IN CERTAIN JURISDICTIONS. THIS NOTICE REQUIRES YOU TO CONFIRM CERTAIN MATTERS (INCLUDING THAT YOU ARE NOT RESIDENT IN SUCH A JURISDICTION) BEFORE YOU MAY OBTAIN ACCESS TO THE INFORMATION ON THIS SECTION OF THE WEBSITE. IF YOU ARE ABLE TO AGREE, PRESS “I AGREE” BELOW. IF YOU ARE UNABLE TO AGREE, YOU SHOULD PRESS “I DECLINE” AND YOU WILL NOT BE ABLE TO VIEW INFORMATION RELATING TO THE OFFER.

THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSIBLE BY PERSONS LOCATED IN ANY JURISDICTION WHERE IT WOULD OR MAY VIOLATE THE LAWS OF THAT JURISDICTION OR WOULD RESULT IN A REQUIREMENT TO COMPLY WITH ANY GOVERNMENTAL OR OTHER CONSENT OR ANY REGISTRATION, FILING OR OTHER FORMALITY WHICH THE CONSORTIUM REGARDS AS UNDULY ONEROUS (“RESTRICTED JURISDICTION”).

If you would like to view the Information on this section of the website, please read this notice carefully. This notice applies to all persons who view the Information contained on this section of the website and, depending on where you are located, may affect your rights or responsibilities. The Consortium reserves the right to amend or update this notice at any time and you should, therefore, read it in full each time you visit this section of the website. In addition, the contents of this section of the website may be amended at any time in whole or in part at the sole discretion of the Consortium.

Basis of access to information

The Information contained in this section of the website does not constitute an offer to sell or otherwise dispose of or an invitation or solicitation of any offer to purchase or subscribe for any securities pursuant to the Offer or otherwise in any jurisdiction in which such offer or solicitation is unlawful. The Offer would be made solely be means of an offer or scheme document which would contain the full terms and conditions of such Offer, including details on how it may be accepted. Any decision made in relation to the Offer should be made solely and only on the basis of the information provided in any such document. Any person who proceeds to access this section of the website thereby represents and warrants to the Consortium that they are doing so for information purposes only.

The Information speaks only at the date of the relevant document, announcement, communication or information. Other than to the extent such duty arises as a matter of law or regulation, the Consortium has, and accepts, no, and expressly disclaims any, responsibility or duty to update or revise any Information and reserves the right to add to, remove or amend any Information reproduced on this section of the website at any time.

In relation to any Information, the only responsibility accepted by the Consortium is for the correctness and fairness of its reproduction or presentation unless a responsibility statement in any relevant document expressly provides otherwise.

Neither the Consortium, nor any of their affiliated companies, have reviewed, and no such person is, or shall be, responsible for or accepts any liability in respect of, any information contained on any other website which may be linked to or from this section of the website.

If you are in any doubt about the contents of this section of the website or any action you should take, you should seek your own financial advice from an appropriately authorised independent financial adviser.

The Information is subject to, and must be read in conjunction with, all other publicly available information and, where relevant, any further disclosure document(s) published by the Consortium or Dalata.

This section of the website contains Information that has been prepared for the purposes of complying with the laws of Ireland and the Irish Takeover Rules and the Information disclosed may not be the same as that which would have been disclosed if this Information had been prepared in accordance with the laws and regulations of any jurisdiction outside of Ireland.

This notice shall be governed by and construed in accordance with Irish law. 

Forward-looking statements

This section of the website and the Information may contain certain forward-looking statements with respect to the financial condition, strategies, objectives, results of operations and businesses of the Consortium and/or Dalata following the implementation of the Offer or otherwise.

All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Forward-looking statements are statements of future expectations that are based on management’s current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in these statements. Forward-looking statements include, amongst other things, statements expressing management’s expectations, beliefs, estimates, forecasts, projections and assumptions, including as to future potential cost savings, synergies, earnings, cash flow, return on capital employed, production and prospects. These forward-looking statements are identified by their use of terms and phrases such as ‘anticipate’, ‘target’, ‘expect’, ‘estimate’, ‘intend’, ‘plan’, ‘goal’, ‘believe’, ‘hope’, ‘aims’, ‘continue’, ‘will’, ‘may’, ‘should’, ‘would’, ‘could’ and similar terms and phrases.

These statements are based on assumptions and assessments made by the Consortium and/or Dalata in light of their experience and their perception of historical trends, current conditions, future developments and other factors they believe appropriate. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. The factors described in the context of such forward-looking statements in the Information could cause actual results and developments to differ materially from those expressed in or implied by such forward-looking statements. Although it is believed that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct.

There are several factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among such factors are changes in the global, political, economic, business, competitive, market and regulatory forces, future exchange and interest rates, changes in tax rates and future business combinations or disposals.

All forward-looking statements contained on this section of the website are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements.

Each forward-looking statement speaks only as at the specified date of the relevant document within which the statement is contained. Other than to the extent such duty arises as a matter of law or regulation, the Consortium undertakes no obligation to publicly update or revise any forward-looking statement as a result of new information, further events or other information.

Unless expressly stated otherwise, no statement contained or referred to on this section of the website is intended to be a profit forecast.

Overseas persons

This Information is not directed at or intended to be accessible by persons resident in any Restricted Jurisdiction. 

Viewing the Information on this section of the website may be unlawful if you are resident in a Restricted Jurisdiction. In certain jurisdictions, including Restricted Jurisdictions, only certain categories of persons may be allowed to view such materials. Any person resident outside of Ireland who wishes to access the Information must first satisfy themselves that they are not subject to any local requirements that prohibit or restrict them from doing so and should inform themselves about, and observe, any legal or regulatory requirements applicable in their jurisdiction. Neither the Consortium nor any of its respective advisers assumes any responsibility for any violation by any person of any of these restrictions.

It is your responsibility to satisfy yourself as to the full observance of any relevant laws and regulatory requirements. If you are not permitted to view the Information on this section of the website, or are in any doubt as to whether you are permitted to view the Information, please select “I DECLINE” to exit this section of the website.

By selecting “I AGREE”, you represent that you are not a national of, or resident in, a Restricted Jurisdiction, and that the Consortium is lawfully entitled to make the content of any communication or document in relation to the Offer available to you under applicable securities laws. If you are unable to give this representation, do not view the content of any of the Information and select “I DECLINE”.

YOU SHOULD NOT DOWNLOAD, MAIL, FORWARD, DISTRIBUTE, SEND OR SHARE THE INFORMATION OR DOCUMENTS CONTAINED ON THIS SECTION OF THE WEBSITE TO ANY PERSON. IN PARTICULAR, YOU SHOULD NOT MAIL, FORWARD, DISTRIBUTE OR SEND THE INFORMATION OR DOCUMENTS CONTAINED THEREIN TO ANY RESTRICTED JURISDICTION.

Confirmation of understanding and acceptance 

By clicking “I AGREE” below, you hereby acknowledge that: (i) you have read and understood the notice set out above and agree to be bound by its terms; (ii) you are not (and do not act on behalf of someone who is) resident in any country that renders the accessing of the materials on this section of the website or parts of it illegal; (iii) you represent and warrant to the Consortium that you intend to access this section of the website for information purposes only; and (iv) you will not print, download, or otherwise seek to copy, mail, forward, distribute or send any of the materials on this section of the website to any other person at any time.

If you are not able to give these confirmations, you should click on “I DECLINE” below.

I have read and understood the disclaimer set out above. I understand that it may affect my rights and I agree to be bound by its terms. I confirm that I am permitted to proceed to electronic versions of the materials. 

Offer for Dalata Hotel Group plc

Offer related announcements 

Rule 2.4 announcement dated 3 June 2025 | Visit Link to RNS

Rule 2.4 announcement daterad 3 juni 2025

Rule 2.4 announcement dated 20 June 2025 Visit link to RNS

Rule 2.4 announcement daterad 20 juni 2025

Rule 2.7 announcement dated 15 July 2025 | Visit link to RNS

Rule 2.7 related announcement dated 15 July 2025 | Visit link to RNS

Pandox AB (publ): Förvärv av aktier i Dalata Hotel Group plc daterad 24 juli 2025

Announcement of scheme document and timetable dated 12 August 2025Visit link to RNS

Scheme documents

Scheme document dated 12 August 2025

Form of Proxy - First Scheme Meeting

Form of Proxy - Second Scheme Meeting

Form of Proxy - EGM

Offer related documents

Bid conduct agreement dated 15 July

Bidco deed of release dated 15 July 2025

Confidentiality agreement dated 26 June 2025

Dalata deed of indemnity dated 15 July 2025

Deed of Amendment to the Transaction Agreement dated 11 August 2025

Transaction Agreement dated 15 July 2025

Valuation report dated 15 July 2025

Financing documents

Facilities agreement dated 15 July 2025

Equity financing agreement dated 11 August 2025

Letter of consent from Goodbody Stockbrokers dated 12 August 2025

Letter of consent from Rothschild & Co dated 12 August 2025

Letter of consent from JLL dated 11 August 2025

Rule 15 documents

Rule 15 letter to Ireland SAYE optionsholders dated 14 August 2025

Rule 15 letter to LTIP participants dated 14 August 2025

Rule 15 letter to UK SAYE optionholders dated 14 August 2025

Rule 15 announcement dated 14 August 2025 | Visit link to RNS

Constitutional documents

Constitution of Pandox Ireland Tuck Limited

Articles of Association of Pandox AB

Articles of Association of Eiendomsspar AS

Constitution of Dalata Hotel Group plc

Director and shareholder irrevocable undertakings

Directors Irrevocable Undertaking dated 15 July 2025 - Carol Phelan

Directors Irrevocable Undertaking dated 15 July 2025 - Dermot Crowley

Directors Irrevocable Undertaking dated 15 July 2025 - Des McCann

Directors Irrevocable Undertaking dated 15 July 2025 - Elizabeth McMeikan

Directors Irrevocable Undertaking dated 15 July 2025 - Gervaise Slowey

Directors Irrevocable Undertaking dated 15 July 2025 - John Hennessy

Directors Irrevocable Undertaking dated 15 July 2025 - Shane Casserly

Shareholder Irrevocable Undertaking dated 15 July 2025 - Eiendomsspar AS

Shareholder Irrevocable Undertaking dated 15 July 2025 - Pandox Ireland DAC

Opening position and dealing disclosures

Form 8.1 (a) & (b) OPD (Pandox AB and Eiendomsspar AS) dated 16 June 2025Visit link to RNS

Form 8.1 (Pandox AB & Eiendomsspar AS) dated 24 July 2025 | Visit link to RNS

Form 8.1 (Pandox AB & Eiendomsspar AS) dated 23 June 2025 | Visit link to RNS

Financial information

Dalata 2024 Annual Report

Dalata 2023 Annual Report

Eiendomsspar 2024 Annual Report

Eiendomsspar 2023 Annual Report

Pandox 2024 Annual Report

Pandox 2023 Annual Report 

Pandox January–June 2025 Interim Report

Pandox January–March 2025 Interim Report

Other Documents

Goodbody aggregation of dealings

Dalata aggregation of dealings